Researchers find potential in yeast for selecting Lou Gehrig's disease drugs April 17th, 2008 in Medicine & Health / Diseases, Conditions, Syndromes Researchers from the University of Pennsylvania School of Medicine are developing a novel approach to screen for drugs to combat neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, using yeast cells.